-
2
-
-
10744223370
-
Tobacco and cancer: Recent epidemiological evidence
-
Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96: 99-106.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 99-106
-
-
Vineis, P.1
Alavanja, M.2
Buffler, P.3
-
3
-
-
0031748213
-
Uncovering the effects of smoking: Historical perspective
-
Doll R. Uncovering the effects of smoking: historical perspective. Stat Methods Med Res 1998; 7: 87-117.
-
(1998)
Stat Methods Med Res
, vol.7
, pp. 87-117
-
-
Doll, R.1
-
4
-
-
0034609239
-
Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies
-
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323-329.
-
(2000)
BMJ
, vol.321
, pp. 323-329
-
-
Peto, R.1
Darby, S.2
Deo, H.3
Silcocks, P.4
Whitley, E.5
Doll, R.6
-
5
-
-
0034745389
-
Patterns of p53 G to T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
-
Hainaut P, Pfeifer GP. Patterns of p53 G to T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22: 367-374.
-
(2001)
Carcinogenesis
, vol.22
, pp. 367-374
-
-
Hainaut, P.1
Pfeifer, G.P.2
-
6
-
-
0036313209
-
Human urinary carcinogen metabolites: Biomar-kers for investigating tobacco and cancer
-
Hecht SS. Human urinary carcinogen metabolites: biomar-kers for investigating tobacco and cancer. Carcinogenesis 2002; 23: 907-922.
-
(2002)
Carcinogenesis
, vol.23
, pp. 907-922
-
-
Hecht, S.S.1
-
7
-
-
0030873467
-
The accumulated evidence on lung cancer and environmental tobacco smoke
-
Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-988.
-
(1997)
BMJ
, vol.315
, pp. 980-988
-
-
Hackshaw, A.K.1
Law, M.R.2
Wald, N.J.3
-
8
-
-
0032550671
-
Why review articles on the health effects of passive smoking reach different conclusions
-
Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998; 279: 1566-1570.
-
(1998)
JAMA
, vol.279
, pp. 1566-1570
-
-
Barnes, D.E.1
Bero, L.A.2
-
9
-
-
41249083827
-
The association of smoking and cardiovascular disease in a population with low cholesterol levels: A study of 648,346 men from the Korean national health system prospective cohort study
-
Lawlor DA, Song YM, Sung J, Ebrahim S, Smith GD. The association of smoking and cardiovascular disease in a population with low cholesterol levels: a study of 648,346 men from the Korean national health system prospective cohort study. Stroke 2008; 39: 760-767.
-
(2008)
Stroke
, vol.39
, pp. 760-767
-
-
Lawlor, D.A.1
Song, Y.M.2
Sung, J.3
Ebrahim, S.4
Smith, G.D.5
-
10
-
-
0031717255
-
Putative susceptibility markers of coronary artery disease: Association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue
-
Van Schooten FJ, Hirvonen A, Maas LM, et al. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 1998; 12: 1409-1417.
-
(1998)
FASEB J
, vol.12
, pp. 1409-1417
-
-
Van Schooten, F.J.1
Hirvonen, A.2
Maas, L.M.3
-
11
-
-
9144246960
-
Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts
-
Li JM, Cui TX, Shiuchi T, et al. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts. Arterioscler Thromb Vasc Biol 2004; 24: 80-84.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 80-84
-
-
Li, J.M.1
Cui, T.X.2
Shiuchi, T.3
-
12
-
-
36549061419
-
Chronic disease prevention: Health effects and financial costs of strategies to reduce salt intake and control tobacco use
-
Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370: 2044-2053.
-
(2007)
Lancet
, vol.370
, pp. 2044-2053
-
-
Asaria, P.1
Chisholm, D.2
Mathers, C.3
Ezzati, M.4
Beaglehole, R.5
-
13
-
-
33845338724
-
Projections of global mortality and burden of disease from 2002 to 2030
-
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
-
(2006)
PLoS Med
, vol.3
-
-
Mathers, C.D.1
Loncar, D.2
|